Bleeding risk with ischemic stroke therapy

JAMA. 2012 Oct 3;308(13):1318-9; author reply 1319-20. doi: 10.1001/2012.jama.11664.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Brain Ischemia / epidemiology*
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Male
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / administration & dosage*
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Warfarin
  • Tissue Plasminogen Activator